This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Development Center for Biotechnology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chen-Jei Hong: Innovator in Antibody Development
Introduction
Chen-Jei Hong is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Chen-Jei Hong holds a patent for "Anti-CD73 antibodies and use thereof." This invention relates to a novel antibody and an antigen-binding fragment that specifically binds to human CD73 at designated epitopes. The patent highlights the specific complementarity-determining regions (CDRs) that are crucial for the antibody's functionality.
Career Highlights
Chen-Jei Hong is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in antibody technology. His expertise and innovative approach have positioned him as a key figure in his field.
Collaborations
Some of his notable coworkers include Chun-Chung Lee and Yu-Hsun Lo. Their collaborative efforts contribute to the ongoing research and development initiatives at the Development Center for Biotechnology.
Conclusion
Chen-Jei Hong's work in antibody development exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for advancements in medical treatments and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile